Tocovid Attenuated Oxidative Stress and Cognitive Decline by Inhibiting Amyloid-β-Induced NOX2 Activation in Alzheimer’s Disease Mice
Journal of Alzheimer's Disease · 2024
DOI: 10.3233/jad-220761 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Alzheimer's Disease, 2024. Verfasst von Zhihong Bian und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Kita-ku, Okayama, Japan. Hauptthemen laut MEDLINE: Alzheimer Disease, NADPH Oxidase 2, Oxidative Stress, Mice, Transgenic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben.
Themen: Demenz
Abstract (Originalsprache)
Background
NADPH oxidase 2 (NOX2) is an important source of reactive oxygen species (ROS). Activated NOX2 may contribute to Alzheimer’s disease (AD). Our previous studies showed that a novel vitamin E mixture, Tocovid, had potential neuroprotective effects in a stroke mice model and an AD cell model.
Objective
The aim of this study was two-fold: to assess whether long-term Tocovid treatment can regulate NOX2, and the therapeutic effects of long-term administration of Tocovid to an AD mice model.
Methods
Therapeutic effects of long-term administration of Tocovid (200 mg/kg /day) on an Aβ-overexpressed transgenic AD mice model (APP23, n = 8) was investigated. The therapeutic effect of Tocovid in 16-month-old mice compared with the no-treatment APP23 group (n = 9) was assessed.
Results
Tocovid treatment strongly improved motor and memory deficits of APP23 mice by attenuating NOX2 expression, oxidative stress, neuroinflammation, neurovascular unit dysfunction, synaptic alteration, and Aβ deposition after 16 months.
Conclusion
These findings suggest that NOX2 is a potential target in AD pathology. Long-term administration of Tocovid may be a promising candidate for AD treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Kita-ku, Okayama, Japan.
- National Center Hospital, National Center of Neurology and Psychiatry, Kodaira-shi, Tokyo, Japan.
Zitieren
APA
Bian, Z., Yu, H., Hu, X., Bian, Y., Sun, H., Tadokoro, K., Takemoto, M., Yunoki, T., Nakano, Y., Fukui, Y., Morihara, R., Abe, K., & Yamashita, T. (2024). Tocovid Attenuated Oxidative Stress and Cognitive Decline by Inhibiting Amyloid-β-Induced NOX2 Activation in Alzheimer’s Disease Mice. Journal of Alzheimer's Disease. https://doi.org/10.3233/jad-220761
Vancouver
Bian Z, Yu H, Hu X, Bian Y, Sun H, Tadokoro K, et al. Tocovid Attenuated Oxidative Stress and Cognitive Decline by Inhibiting Amyloid-β-Induced NOX2 Activation in Alzheimer’s Disease Mice. Journal of Alzheimer's Disease. 2024. doi:10.3233/jad-220761
BibTeX
@article{Bian2024,
author = {Bian, Zhihong and Yu, Haibo and Hu, Xinran and Bian, Yuting and Sun, Hongming and Tadokoro, Koh and Takemoto, Mami and Yunoki, Taijun and Nakano, Yumiko and Fukui, Yusuke and Morihara, Ryuta and Abe, Koji and Yamashita, Toru},
title = {Tocovid Attenuated Oxidative Stress and Cognitive Decline by Inhibiting Amyloid-β-Induced NOX2 Activation in Alzheimer’s Disease Mice},
journal = {Journal of Alzheimer's Disease},
year = {2024},
doi = {10.3233/jad-220761}
}
EUVIMED